Your browser doesn't support javascript.
loading
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
Thompson, John A; Schneider, Bryan J; Brahmer, Julie; Andrews, Stephanie; Armand, Philippe; Bhatia, Shailender; Budde, Lihua E; Costa, Luciano; Davies, Marianne; Dunnington, David; Ernstoff, Marc S; Frigault, Matthew; Kaffenberger, Benjamin H; Lunning, Matthew; McGettigan, Suzanne; McPherson, Jordan; Mohindra, Nisha A; Naidoo, Jarushka; Olszanski, Anthony J; Oluwole, Olalekan; Patel, Sandip P; Pennell, Nathan; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A; Wang, Yinghong; Weight, Ryan M; Johnson-Chilla, Alyse; Zuccarino-Catania, Griselda; Engh, Anita.
Afiliación
  • Thompson JA; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Schneider BJ; University of Michigan Rogel Cancer Center.
  • Brahmer J; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Andrews S; Moffitt Cancer Center.
  • Armand P; Dana-Farber/Brigham and Women's Cancer Center.
  • Bhatia S; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Budde LE; City of Hope National Medical Center.
  • Costa L; O'Neal Comprehensive Cancer Center at UAB.
  • Davies M; Yale Cancer Center/Smilow Cancer Hospital.
  • Dunnington D; Patient Advocate.
  • Ernstoff MS; Roswell Park Comprehensive Cancer Center.
  • Frigault M; Massachusetts General Hospital Cancer Center.
  • Kaffenberger BH; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Lunning M; Fred & Pamela Buffett Cancer Center.
  • McGettigan S; Abramson Cancer Center at the University of Pennsylvania.
  • McPherson J; Huntsman Cancer Institute at the University of Utah.
  • Mohindra NA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Naidoo J; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Olszanski AJ; Fox Chase Cancer Center.
  • Oluwole O; Vanderbilt-Ingram Cancer Center.
  • Patel SP; UC San Diego Moores Cancer Center.
  • Pennell N; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Reddy S; Stanford Cancer Institute.
  • Ryder M; Mayo Clinic Cancer Center.
  • Santomasso B; Memorial Sloan Kettering Cancer Center.
  • Shofer S; Duke Cancer Institute.
  • Sosman JA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Wang Y; The University of Texas MD Anderson Cancer Center.
  • Weight RM; University of Colorado Cancer Center; and.
  • Johnson-Chilla A; National Comprehensive Cancer Network.
  • Zuccarino-Catania G; National Comprehensive Cancer Network.
  • Engh A; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 18(3): 230-241, 2020 03.
Article en En | MEDLINE | ID: mdl-32135517
ABSTRACT
The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article